KCl has long been used as a convenient stimulus to bypass G protein-coupled receptors (GPCR) and activate smooth muscle by a highly reproducible and relatively "simple" mechanism involving activation of voltage-operated Ca 2ϩ channels that leads to increases in cytosolic free Ca 2ϩ ([Ca 2ϩ ]i), Ca 2ϩ -calmodulin-dependent myosin light chain (MLC) kinase activation, MLC phosphorylation and contraction. This KCl-induced stimulus-response coupling mechanism is a standard tool-set used in comparative studies to explore more complex mechanisms generated by activation of GPCRs. One area where this approach has been especially productive is in studies designed to understand Ca Refs. 67, 85, 87, 108, 120, 147 , and 204 for reviews). However, Ca 2ϩ does not directly activate smooth muscle motor proteins. Rather, phosphorylation of 20-kDa regulatory myosin light chain (MLC) serves as the "switch" to "turn on" smooth muscle actomyosin ATPase activity (17, 26, 61, 162, 175, 199) , increasing cross-bridge cycling rates and muscle contraction (35). Stimuli that increase [Ca 2ϩ ] i elevate MLC phosphorylation levels by increasing the Ca 2ϩ -calmodulin-dependent MLC kinase-to-phosphatase activity ratio (see Ref. 81 for a review). Other kinases may serve the same role because a recent study (181) using MLC kinase knockout (Ϫ/Ϫ) mice shows that arteries still contract, and cells cultured from aorta still display increases in MLC phosphorylation. Nevertheless, the steady-state relationship between cross-bridge phosphorylation and force in swine carotid media stimulated by several contractile agonists is steeply hyperbolic (34, 153, 159) , suggesting that a unique relationship often exists between these two parameters of muscle activation. Thus, based on a stimulus-response operational approach, if the number of cross bridges "switched on" to produce force is uniquely dependent on [Ca 2ϩ ] i , then the sensitivity of contractile force to Ca 2ϩ is invariant. However, studies beginning in the 1980s on intact ferret portal vein (127), ferret (32), and rat aorta (86, 169), rat (142) and swine carotid artery (22, 158), rabbit pulmonary artery (66), rabbit ear artery (64), rabbit femoral artery (150), guinea pig ileum (64), and canine trachea (53, 143) by using the photoprotein, aequorin, and fluorescent Ca 2ϩ indicators, fura-2 and quin-2, show that K ϩ -depolarization and G protein coupled receptor (GPCR) (66, 97, 103, 137) concomitant with increases in MLC phosphorylation (94).
sensitization, the relationship between [Ca 2ϩ ]i and force produced by GPCR agonists. Studies done in the late 1980s demonstrated that a unique relationship between stimulus-induced [Ca 2ϩ ]i and force does not exist: for a given increase in [Ca 2ϩ ]i, GPCR activation can produce greater force than KCl, and relaxant agents can produce the opposite effect to cause Ca 2ϩ desensitization. Such changes in Ca 2ϩ sensitivity are now known to involve multiple cell signaling strategies, including translocation of proteins from cytosol to plasma membrane, and activation of enzymes, including RhoA kinase and protein kinase C. However, recent studies show that KCl can also cause Ca 2ϩ sensitization involving translocation and activation of RhoA kinase. Rather than complicating the Ca 2ϩ sensitivity story, this surprising finding is already providing novel insights into mechanisms regulating Ca 2ϩ sensitivity of smooth muscle contraction. KCl as a "simple" stimulus promises to remain a standard tool for smooth muscle cell physiologists, whose focus is to understand mechanisms regulating Ca 2ϩ sensitivity.
K ϩ depolarization; cell signaling; signal transduction; contraction THE UNIVERSAL CELLULAR regulator, Ca 2ϩ (see Ref. 25 for a review), is the primary signal responsible for activation of smooth muscle contractile proteins (41, 125, 134) . Cytosolic free Ca 2ϩ concentration ([Ca 2ϩ ] i ) is finely tuned by multiple membrane-based Ca 2ϩ channels, pumps, compartments, and intracellular buffers to suit the immediate contractile requirement of muscle cells (see Refs. 67, 85, 87, 108, 120, 147 , and 204 for reviews). However, Ca 2ϩ does not directly activate smooth muscle motor proteins. Rather, phosphorylation of 20-kDa regulatory myosin light chain (MLC) serves as the "switch" to "turn on" smooth muscle actomyosin ATPase activity (17, 26, 61, 162, 175, 199) , increasing cross-bridge cycling rates and muscle contraction (35) . Stimuli that increase [Ca 2ϩ ] i elevate MLC phosphorylation levels by increasing the Ca 2ϩ -calmodulin-dependent MLC kinase-to-phosphatase activity ratio (see Ref. 81 for a review). Other kinases may serve the same role because a recent study (181) using MLC kinase knockout (Ϫ/Ϫ) mice shows that arteries still contract, and cells cultured from aorta still display increases in MLC phosphorylation. Nevertheless, the steady-state relationship between cross-bridge phosphorylation and force in swine carotid media stimulated by several contractile agonists is steeply hyperbolic (34, 153, 159) , suggesting that a unique relationship often exists between these two parameters of muscle activation. Thus, based on a stimulus-response operational approach, if the number of cross bridges "switched on" to produce force is uniquely dependent on [Ca 2ϩ ] i , then the sensitivity of contractile force to Ca 2ϩ is invariant. However, studies beginning in the 1980s on intact ferret portal vein (127) , ferret (32), and rat aorta (86, 169) , rat (142) and swine carotid artery (22, 158), rabbit pulmonary artery (66) , rabbit ear artery (64) , rabbit femoral artery (150) , guinea pig ileum (64) , and canine trachea (53, 143) by using the photoprotein, aequorin, and fluorescent Ca 2ϩ indicators, fura-2 and quin-2, show that K ϩ -depolarization and G protein coupled receptor (GPCR) activation yield different [Ca 2ϩ ] i -force curves and that cyclic nucleotides can cause relaxation with minimal reductions in [Ca 2ϩ ] i (1, 126, 215) . These results are supported by data obtained from Ca 2ϩ -clamped (permeabilized) tissues showing that, at constant Ca 2ϩ concentrations, cyclic nucleotides can induce relaxation (163, 164) , and stimuli activating contractile GPCRs can elevate force (66, 97, 103, 137) concomitant with increases in MLC phosphorylation (94) .
Together, these and other studies provided the material to construct a model (84) showing that the degree of Ca 2ϩ sensitivity is a regulated parameter; mechanisms shifting Ca 2ϩ sensitivity to the left and right of a central curve generated in response to stimulation with KCl cause, respectively, Ca 2ϩ sensitization and Ca 2ϩ desensitization (Fig. 1A) . What has emerged from research over the past 15 years is that Ca 2ϩ sensitivity plays as important a role in regulation of smooth muscle contraction as does [Ca 2ϩ ] i (see Refs. 70, 91, 145, 170, 176 , and 178 for reviews). Moreover, until recently, regulation of Ca 2ϩ sensitivity has been attributed solely to Ca 2ϩ -independent cell signaling events. However, as with many cell signaling systems thought originally to reflect a direct cause-andeffect regulatory pathway and found later to involve cross-talk with other signaling systems, regulation of smooth muscle contraction by [Ca 2ϩ ] i and by Ca 2ϩ sensitivity may not always be entirely separate systems, but may best be understood as part of an interacting spatiotemporal signaling network (150, 201, 202) .
MECHANISMS REGULATING SMOOTH MUSCLE CA

2؉
SENSITIVITY
Ca
2ϩ sensitivity is regulated primarily at the level of MLC phosphorylation by modulation of MLC phosphatase activity (93, 94, 105) , but may also be regulated by modulation of MLC kinase activity, and downstream from MLC phosphorylation by mechanisms involving thin filament regulation and possibly direct regulation by heat shock proteins of contractile proteins or load-bearing structures associated with them. Many excellent reviews cover these topics in depth (23, 57, 82, 87, 91, 145, 178, 211) , and only the very general features and historical aspects focusing largely on MLC phosphatase regulation will be covered in this section.
Studies done as early as 1984, with the use of intact smooth muscle tissues, showed that GPCR agonists can produce greater increases in force for a given increase in [Ca 2ϩ ] i than KCl (22, 32, 53, 66, 86, 127, 142, 158, 169 , and 176 for reviews). While the motor proteins responsible for generation of force reside in the cell interior, most of the upstream signals generated upon GPCR stimulation, including ROK and PKC, are regulated at the plasma membrane.
The smooth muscle plasma membrane can be divided into at least three domains: focal contacts, the dystroglycan complex, and caveolae. Caveolae are small 50 -100 nm cavelike invaginations of the plasma membrane housing a unique lipid domain that contains high concentrations of cholesterol and sphingolipids (see Ref. 174 for review). The dystrophin complex and caveolae are complementary (i.e., spatially close), whereas caveolae and focal contacts are located in mutually exclusive areas that display an alternating, punctate pattern when viewed with the use of immunohistochemical fluorescence labeling of selected proteins (see Refs. 58, 138, 192, and Fig. 2) . Several studies support the hypothesis that GPCR stimulation increases translocation of inactive cytosolic RhoA (bound to RhoA-GDI) to peripheral plasma membrane sites such as caveolae, where RhoA-GTP activates ROK (45, 56, 187), supporting a caveolar role in regulation of Ca 2ϩ sensitization (for review, see Ref. 186) . Moreover, the hypothesis that caveolae play an important role in GPCR-induced contraction is supported by data showing that disruption of the caveolar structure with the cholesterol-depleting agent, methyl-␤-cyclodextrin, or by caveolin-1 knockout, reduces the ability of some GPCR stimuli, but not KCl, to produce contraction (36, 37, 78) .
Thus the notion that GPCR stimuli cause Ca 2ϩ sensitization by activation of kinases not "turned on" during K ϩ depolarization is an attractive hypothesis for several reasons, not the least of which is because it permits comparative cell physiological studies designed to reveal underlying mechanisms by which GPCR stimuli cause contraction. In support of the data from intact tissues, GPCR agonists and GTP␥S were found to elevate force in Ca 2ϩ -clamped (permeabilized with ␣-toxin or saponin) smooth muscle tissues (46, 97, 137). These data together set the stage for work on mechanisms regulating (96) . MLC phosphatase activity is also regulated independently of CPI-17 by MYPT1-Thr696 and MYPT1-Thr853 phosphorylation. MYPT1-Thr696 phosphorylation inhibits MLC phosphatase activity (42, 71) and MYPT1-Thr853 phosphorylation causes dissociation of MLC phosphatase from myosin, thereby effectively preventing MLC phosphatase from acting on its substrate, phospho-MLC (206) . There is growing evidence that GPCR agonists that cause Ca 2ϩ sensitization in smooth muscle act by increasing MYPT1-Thr853 phosphorylation more so than by increasing MYPT1-Thr696 phosphorylation (96, 136) . Several kinases, including ROK, can phosphorylate MYPT1 and CPI-17 (reviewed by Ref. 75, 178) . Whereas GPCR activation can phosphorylate, KCl does not cause phosphorylation of CPI-17 in the tonic femoral artery or phasic vas deferens in the presence of ␣-adrenergic receptor blockade (95, 96) .
ROK AND PKC PARTICIPATE IN ELEVATING CA
2؉
SENSITIVITY OF MANY SMOOTH MUSCLE TYPES IN RESPONSE TO GPCR STIMULATION
In 1997, Y-27632 was introduced as a Ser/Thr protein kinase inhibitor competitive with ATP at the catalytic site, selective for ROK over PKC, cAMP-dependent protein kinase and MLC kinase, and with an IC 50 value ranging between 0.3 and 1 M for inhibition of contractions produced by rabbit aorta stimulated with phenylephrine, histamine, acetylcholine, serotonin, endothelin, and U-46619 (200) . The IC 50 for inhibition of KCl-induced contraction was reported to be Ͼ30 M, supporting the conclusion that Y-27632 is a specific and potent inhibitor of GPCR-induced smooth muscle contraction (200) . Subsequent work showed that Y-27632 inhibits both ROK isotypes (ROK␣ and ROK␤) with nearly equivalent potencies and is ϳ16-fold more selective for ROK than citron kinase and PKN, other RhoA targets (74) (200) , respiratory (27), ileal (185) , stomach (156) , bladder (79) , and myometrial (106) smooth muscle contractions produced by GPCR stimulation. However, based on the degree to which these agents inhibit force, the extent to which ROK participates in contractions appears to differ in different smooth muscle types. For example, 10 M Y-27632 modestly reduces spontaneous human myometrial contractions (106) yet abolishes tonic ␣-adrenergic receptor-induced contraction of rabbit aorta (200) . Muscarinic receptor stimulation induces a biphasic contraction of ileum, bladder, and chicken gizzard consisting of a phasic component (early peak response), followed by a tonic component that is weaker than the phasic component. In the ileum, ROK blockade by Y-27632 and HA-1077 leaves the phasic component nearly intact and abolishes the tonic component (185) , whereas in the bladder, both components are greatly diminished (79) . Although GTP␥S induces ROK activation and Ca 2ϩ sensitization in chicken gizzard smooth muscle, muscarinic receptor stimulation does not cause ROK-dependent Ca 2ϩ sensitization in this muscle type (6) . However, Y-27632 reduces stomach antrum motility in conscious rats (197) and stomach fundus contraction induced by muscarinic receptor activation in vitro (156) .
EVIDENCE THAT KCL CAN ACTIVATE COMPLEX CELL SIGNALING SYSTEMS
KCl is often used as a tool to bypass GPCR stimulation and activate smooth muscle by changing the K ϩ equilibrium potential and clamping membrane potential at some value above the resting level (reviewed by Ref. 20) . On the basis of the distinctive differences between muscle activation by membrane depolarization and receptor activation, originally termed /calmodulin-dependent protein kinase II (CaMKII), which can cause MLC kinase site A phosphorylation, a reduction in MLC kinase affinity for Ca 2ϩ /calmodulin, and attenuated increases in MLC phosphorylation in airway smooth muscle (184, 194, 195) . KCl can also increase ERK activity in both cultured aortic smooth muscle cells (2) and intact arteries, although the degree of activation may vary from sustained (89) 65, 72, 100, 125, 131, 132, 191, 203) . However, there is evidence that a portion of the early, phasic phase of a KCl-induced smooth muscle contraction is due also to release of Ca 2ϩ from ryanodine-and caffeine-sensitive intracellular Ca 2ϩ stores (101, 102) . In coronary artery, membrane depolarization appears to modulate inositol 1,4,5-trisphosphate production (50). Moreover, selectivity for VOCCs of certain activates MLC kinase (MLCK) to increase MLC phosphorylation and contraction (shown as P on sidepolar thick filament moving actin cables). GPCR stimulation also generates other cell messengers in a (relatively) Ca 2ϩ -independent fashion, causing activation of kinases such as protein kinase C (PKC) and ROK (ROK*, activated Rho kinase) that inhibit MLC phosphatase (MLCP) activity. GPCR activation increases RhoA, ROK and PKC translocation to caveolin (blue hairpin-like structure within caveolar membrane invagination). Inhibition of MLCP activity by phosphorylation of the large molecular weight MLCP regulatory protein, MYPT1, or by phosphorylation of the MLCP inhibitory protein, CPI-17, produces a Ca 2ϩ -independent increase in the MLCK/MLCP activity ratio to further increase MLC phosphorylation and force (Ca 2ϩ sensitization; note that ٛMLCP signifies that MYPT1 phosphorylation by ROK reduces the ability of MLCP to dephosphorylate MLC-p). ROK may directly phosphorylate MYPT1 or may act through other kinases. PKC (and other kinases, including ROK) phosphorylate CPI-17 causing MLCP inhibition. Other modes of potential Ca 2ϩ sensitization, including additional forms of regulation of MLCK activity and thin filament regulation, are not shown. VOCC, voltage-operated Ca 2ϩ channel; SOCC, store-operated Ca 2ϩ channel; ROCC, receptor-operated Ca 2ϩ channel.
organic Ca 2ϩ channel blockers, such as the dihydropyridine, nifedipine, has recently been challenged. Although nonselective actions at high concentrations of organic Ca 2ϩ channel blockers are well known (83) , recent studies (104, 109, 209) suggest that low nifedipine concentrations inhibit certain storeoperated Ca 2ϩ channels (SOCCs) with an IC 50 value equivalent to VOCC inhibition (28, 216). Although additional research is required, these data together support the hypothesis that smooth muscle membrane depolarization by KCl may stimulate more complex Ca 2ϩ signaling systems than simply activation of VOCCs.
In 1990, the isoquinolinesulfonyl protein kinase inhibitor, H-7, was shown to more potently relax KCl-induced (IC 50 ϳ4 M) than phenylephrine-induced (IC 50 ϭ 11-15 M) tonic contractions of rabbit renal and femoral arteries (148) . Reductions in force correlated with reductions in MLC phosphorylation and the maximum rate of muscle shortening (148) . In the rat aorta, H-7 inhibits KCl-induced increases in force more strongly than increases in [Ca 2ϩ ] i (190) . At the time of these studies, H-7 was considered a selective PKC inhibitor (63, 73, 90) , and the data suggested involvement of PKC in KClinduced tonic force maintenance. Another isoquinolinesulfonyl protein kinase inhibitor and potent vasorelaxant, HA-1077 when used at no more than 10 M, was shown to also strongly inhibit KCl-induced contractions with a minimum inhibition of [Ca 2ϩ ] i (190) . In canine basilar artery, 10 M HA-1077 abolishes Ca 2ϩ ionophore (ionomycin)-induced contraction, whereas organic Ca 2ϩ channel blockers have no effect, suggesting that the inhibitory effect is due to intracellular antagonism of contraction (189) . The K i for MLC kinase is 36 M (11), and at 20 M, HA-1077 inhibits MLC kinase by Ͻ10% (31). These data, acquired before the discovery of ROK in 1995 (111) , suggested that KCl stimulates a kinase other than MLC kinase that plays an important role downstream from Ca 2ϩ mobilization in the regulation of smooth muscle contraction. It is now clear that H-7 (43) and HA-1077 inhibit ROK with nearly equal potency (200) , that the IC 50 value is ϳ3 M for inhibition of GTP␥S-stimulated contraction of Ca 2ϩ -clamped (␤-escin) guinea pig ileum (185) , and that HA-1077 is a poor inhibitor of conventional PKC isotypes (31, 185). KCl-induced tonic contraction of rabbit femoral artery is not inhibited by 1 M of the bisindolymaleimide, GF-109203X (202) , an effective and relatively selective inhibitor of conventional and novel PKC isotypes with no inhibitory activity toward ROK at concentrations effective against PKC (31, 40, 49 (154, 155) . This Ca 2ϩ desensitization of KCl-induced tonic contraction by prior GPCR is reversed within a few hours (149) , which is consistent with the hypothesis that the KCl-induced Ca 2ϩ sensitivity curve is not unique (150, 214) . Thus the degree of Ca 2ϩ sensitivity produced by both GPCR and KCl stimulation is not fixed, but depends on the concentration of stimulus (47, 214) , and for a given stimulus concentration, on the history of prior receptor activation (150) , suggesting that Ca 2ϩ sensitivity induced by both GPCR stimuli and KCl may fall within a range of values (Fig. 1B) .
However, the argument that a stimulus increases Ca ] i -force curve that is leftward shifted compared with that produced by KCl remains a valid argument, provided that consideration be made for the degree of Ca 2ϩ sensitivity already induced by KCl. For example, the absence of a leftward shift in the [Ca 2ϩ ] i force curve produced by a novel GPCR agonist compared with the KCl-induced curve does not necessarily mean the absence of Ca 2ϩ sensitization. However, the terminology remains loose, and an exact definition for the midpoint of the Ca 2ϩ sensitivity spectrum representing neither Ca 2ϩ sensitization nor Ca 2ϩ desensitization should probably be eliminated. In its place, the two extremes of Ca 2ϩ sensitivity should be defined and mechanistically equated with well-characterized signaling mechanisms.
Recent studies show that Y-27632 inhibits KCl-induced contraction of most smooth muscle types in many species, including the human myometrium (106), rat caudal artery (121), rat (6, 166) and rabbit aorta (166, 167) , rat mesenteric artery (9, 166) , rabbit femoral and renal arteries (202) , mouse anococcygeus smooth muscle (13) , pig and cow airway smooth muscle (77) , and sheep ureter (113) . KCl-induced contraction of chicken gizzard smooth muscle is not inhibited by 10 M Y-27632, but this is consistent with the lack of inhibition by Y-27632 of GPCR stimulation in this smooth muscle despite the presence of RhoA and ROK and the ability to induce Ca 2ϩ sensitization with GTP␥S in Ca 2ϩ -clamped tissues (6). Y-27632 inhibits the tonic phase much more than the early phase of a KCl-induced contraction in rabbit femoral and renal arteries (202) and rat caudal artery (121), whereas 30 M ML-9, a MLC kinase and ROK inhibitor (15, 200) , attenuates both early and tonic force (121) . Y-27632 inhibits KCl-induced force without inhibition of KCl-induced increases in [Ca 2ϩ ] i (77, 106, 121, 166, 202) , but with concomitant inhibition of MLC phosphorylation (121, 166, 202) . However, in the phasic rat ureter, 1 M Y-27632 dramatically inhibits VOCC activity to reduce both [Ca 2ϩ ] i and force produced by electrical field stimulation, whereas action potential-generated force transients in guinea pig ureter are insensitive to Y-27632 (172) . Y-27632 (10 M) has also been shown to modestly inhibit muscarinic receptor-induced increases in [Ca 2ϩ ] i in guinea pig airway smooth muscle (76 (200) . First, a subsequent report by Sakamoto et al. (166) indicates that even 100 M Y-27632 inhibits KCl-contracted rabbit aorta by only 45%, and with this minimum included in the calculation, the IC 50 value is 1.6 M, a value comparable to that calculated for tissues activated by GPCR agonists. Thus, in this artery, the tonic phase of a KCl-induced contraction may consist of a Y-27632-resistant and Y-27632-sensitive component. A second reason is that the potency of inhibition of agonist-induced contraction by Y-27632 is dependent on agonist concentration. In rabbit femoral artery, the order of potency for inhibition by Y-27632 of contraction is 0.1 M phenylephrine ϾKCl and 1 M phenylephrine Ͼ100 M phenylephrine (Fig. 4) , and in bovine airway smooth muscle, although the IC 50 value for inhibition of 0.3 M methacholineinduced contraction is 2.4 M, this concentration of Y-27632 fails to inhibit contractions produced by 1 and 3 M methacholine (130) . Interestingly, in the rat aorta (166), 73 mM KCl-induced contraction is more potently (IC 50 ϳ1 M) inhibited by Y-27632 than are contractions produced by 1 M phenylephrine (IC 50 ϳ2 M), 30 nM endothelin (IC 50 ϳ4 M), and 10 M PGF 2␣ (IC 50 ϳ5 M), which is consistent with the earlier finding that the ROK inhibitor, H-7, produces a more potent inhibition of KCl-induced contraction than of phenylephrine-induced contraction (148) .
POTENTIAL MECHANISMS FOR KCL-INDUCED INCREASES IN CA 2؉ SENSITIVITY
Because KCl bypasses GPCRs and activates smooth muscle by causing membrane depolarization, the realization that KCl can cause ROK-dependent Ca 2ϩ sensitization is somewhat surprising, and precisely how KCl activates ROK is not yet fully understood. ROK was identified as a ubiquitously expressed, 160-kDa protein that specifically interacts with RhoA-GTP and induces stress fiber and focal adhesion formation (111, 112, 119) . Before the discovery of ROK, Ridley and Hall showed in 1992 (160) that RhoA regulates stress fiber and focal adhesion formation in cells stimulated with extracellular ligands, such as lysophosphatidic acid, that activate GPCRs. ROK, an AGC Ser/Thr kinase family member, was the first RhoA effector identified (112) , and is expressed in vertebrates as two isoforms, ROK␣ (ROCKII) and ROK␤ (ROCKI). ROK␣ is abundant in muscle and brain and is distributed mostly, but not exclusively, in the cytosol. Stimuli that activate RhoA cause some ROK translocation to peripheral sites, most notably those associated with caveolin (reviewed by Ref. 187 ). Like other AGC Ser/Thr kinase family members, ROK exists in a closed, inactive conformation in which the COOH terminus (that includes a RhoA binding region and a plekstrin homology domain split by a Cys-rich region) acts as an autoinhibitory domain (4) , and an open, active conformation (for reviews, see Refs. 5, 19, 161) . RhoA induces a modest ϳ2-fold increase in ROK activity, whereas 30 M arachidonic acid increases ROK activity by 5-to 6-fold independently of RhoA (43) by relieving autoinhibition (7). Arachidonic acid produces strong Ca 2ϩ sensitization in Ca 2ϩ -clamped smooth muscle (7, 44) , and several GPCR agonists generate arachidonic acid as a cellular messenger (55). High Ca 2ϩ levels induce substantial arachidonic acid release in permeabilized rabbit femoral artery (55). However, although K ϩ depolarization of smooth muscle can cause significant increases in [Ca 2ϩ ] i , KCl-induced contractions in rabbit thoracic aorta are not inhibited by the PLA 2 inhibitor ONO-RS-082 (16, 122) .
Before publication of Y-27632 as a ROK inhibitor (200), studies using cell-permeable RhoA inhibitors demonstrated attenuation of KCl-induced contractions. For example, Clostridium difficile toxin B reduces the peak of KCl-stimulated phasic contraction of guinea pig intestine by ϳ30% (141), and DC3B (12, 21) significantly inhibits KCl-induced peak contraction of rabbit portal vein by ϳ40% (45). The focus of these studies, however, was on inhibition of GPCR-induced contraction, and inhibition of KCl-induced force was not explored further. Nevertheless, RhoA seems to be involved in KCl-induced ROK activation. Although Ca 2ϩ calmodulin-dependent ras GEFs exist, there are no reports of Ca 2ϩ -or depolarization-dependent RhoA GEFs. Thus there is not yet a viable model to explain how KCl might activate RhoA.
One function of caveolae is to serve as a signalosome (reviewed in Ref. 173 ), a subcellular compartment acting somewhat Fig. 4 . Steady-state force produced by KCl and 0.1, 1, and 100 M phenylephrine (PE), an ␣1-adrenergic receptor agonist (A), and inhibitory potencies of Y-27632 (B), and GF-109203X (C) in rabbit femoral artery. The degree of ROK-dependent Ca 2ϩ sensitization induced by 110 mM KCl (substituted isosmotically for Na ϩ ), as measured by the inhibitory potency of Y-27632, can be considered Ͼ, ϭ, or Ͻ that induced by GPCR stimulation, depending on GPCR activation level (B). The potency of GF-109203X is also dependent on GPCR activation level, but KCl-induced contraction is not inhibited by 1 M GF-109203X, a concentration that strongly inhibits conventional and novel PKC isotypes but has negligible inhibitory activity against ROK. Fo ϭ maximum force produced by KCl at the optimum length for muscle contraction. Data are means Ϯ SE, n ϭ 3-4; *P Ͻ 0.05 compared with KCl.
like an urban center to concentrate signaling molecules and systems, permitting efficient signal transduction. Caveolae are loci for ROK and RhoA interaction upon GPCR stimulation in smooth muscle (186) , and a recent report indicates that caveolin-1 plays a crucial role in regulation of PKC-and ERK-based smooth muscle contraction (78) . Whereas GPCR stimuli cause increased ROK and RhoA colocalization with caveolin (187, 188), KCl increases ROK, but not RhoA, colocalization with caveolin in intact rabbit femoral artery (201, 202) . The fraction of RhoA colocalized basally with caveolin at the plasma membrane in rabbit artery appears to be substantial (201) , and because membrane-bound RhoA is active (the inactive form is bound to Rho-GDI in the cytosol, see Ref. 178 for a review), any ROK that translocates to plasma membrane RhoA may become activated. Moreover, using a pull-down assay, Sakurada et al. (167) found that KCl increases the amount of cellular RhoA in the active (GTP bound) form, and that this stimulation is entirely Ca 2ϩ -dependent in rabbit aorta. These data suggest that KCl may cause Ca 2ϩ sensitization, in part, by increasing the fraction of active ROK at caveolae. However, intact caveolae are not required for KCl-induced contraction, because neither caveolin-1 knockout nor cholesterol depletion causing caveolae collapse alters the ability of KCl to cause contraction (36, 37, 78). Caveolin not only is found in caveolae but also is associated with the ␤-dystroglycan (157) in a plasma membrane domain near caveolae (138, 192) . Thus an alternative hypothesis consistent with the data that has not yet been tested is that RhoA and ROK do not require caveolin as a binding partner for activation and that KCl causes an increase in translocation of ROK to the dystroglycan complex located next to, but not within, caveolae. Although ␣ 1 -adrenergic receptor activation causes Ca 2ϩ sensitization (66, 94) at agonist concentrations greater than the EC 50 value (48) and contraction that is sensitive to inhibition by Y-27632 (see Fig. 4 ), caveolin-1 knockout and caveolar collapse do not inhibit force produced by stimulation of this GPCR (29, 36). Thus, it appears that caveolae are necessary for some but not all stimuli that cause ROK activation and Ca 2ϩ sensitization. A complicating factor in the interpretation of caveolin-1 knockout and caveolar collapse data is that many GPCR-linked signaling molecules other than RhoA and ROK, such as the receptors themselves, G proteins, and PLC␤ that accumulate in caveolae would likewise be disrupted. For example, cholesterol depletion can reduce the affinity of receptors for their ligands (98) . Caveolae also appear to play a dominant role in regulation of membrane potential and Ca 2ϩ signaling (14, 30) , especially activation of SOCCs (18, 198) , and collapse of caveolae can reduce GPCRinduced Ca 2ϩ entry (18, 37) . Thus inhibition of GPCR stimulated contraction may reflect alterations in signaling other than those involved in ROK-induced Ca 2ϩ sensitization. Although KCl doubles the amount of ROK found colocalized with caveolin in the cell periphery in rabbit femoral artery, the increase is from ϳ18% basal colocalization to ϳ35% (202) , suggesting that a majority of ROK either is not translocated to peripheral sites or is translocated to other sites. These data together indicate that a major challenge will be to determine precisely what roles peripheral sites play in ROK activation leading to KCl (and GPCR)-induced Ca 2ϩ sensitization.
How KCl causes ROK translocation to peripheral sites also remains to be determined. The directed movement from cytosol to specific plasma membrane locations suggests that ROK is cargo carried by molecular motors along intracellular cables (reviewed by Refs. 33, 80, 207) . Microtubules that run along the long axis of the smooth muscle cell can be found near the caveolar membrane domain (Fig. 5 and Ref. 118) , and not only do actin cables terminate nearby at focal contacts (192) , but caveolae are largely immobilized by linkage to the cortical actin cytoskeleton, at least in certain cell types (196) . Myosin II is known to transport vesicles along actin cables in clam oocyte extracts (210) , but perhaps more importantly, myosin II colocalizes with cortical actin cables in chromaffin cells where MLC phosphorylation appears necessary for KCl-induced vesicle transport and secretion (133) . Neuronal mitochondria are transported by molecular motors along microtubule and actin cables (128) , and because of the propinquity of mitochondria, caveolae, microtubules and actin cables in smooth muscle (Fig.  5) , it is tempting to speculate that KCl causes Ca 2ϩ sensitization by activating a transport mechanism involving ROK attached to a molecular motor running along an actin or microtubule cable. Interestingly, both the actin polymerization inhibitor, cytochalasin D, and the microtubule disruptor, nocodazole, inhibit the increase in KCl-induced ROK colocalization with caveolin in rabbit artery (Fig. 6) , and cytochalasins A, B, and D inhibit tonic but not early, phasic KCl-induced contraction in rat aorta (212) . In this scenario, ROK need not be active for transport to occur because Y-27632, while strongly inhibiting KCl-induced tonic force, does not inhibit KCl-induced ROK colocalization with caveolin (202) .
On the basis of the current data, one hypothesis for regulation of KCl-induced contraction is a Ca 2ϩ -activated Ca 2ϩ sensitivity model whereby the early increase in Ca 2ϩ activates MLC kinase to activate contraction at myofilaments in the cell interior, but also activates a transport mechanism permitting movement of ROK to peripheral plasma membrane sites. Although speculative, this model is testable and consistent with the recent finding that Y-27632 does not, but both nifedipine and the Ca 2ϩ -calmodulin blocker, trifluoperazine, do inhibit KCl-induced ROK translocation to caveolin in rabbit artery (202) . Moreover, the dihydropyridine Ca 2ϩ channel agonist, BAY K 8644, and the Ca 2ϩ ionophore, ionomycin, likewise cause increases in MLC phosphorylation and force that are inhibited by Y-27632 and increase the amount of ROK colocalization with caveolin that is inhibited by trifluoperazine, suggesting that Ca 2ϩ , rather than membrane depolarization, plays the predominant role in activating ROK, at least in rabbit artery (202) . Any receptor agonist that increases [Ca 2ϩ ] i would necessarily share this mechanism with KCl but additionally would produce a greater increase in Ca 2ϩ sensitivity (150), presumably by activation of PKC (40, 95, 187) and by causing stronger increases ROK activity (reviewed by Ref. 177) . This model will certainly require modification as new data are acquired, but it also assumes that Ca 2ϩ is the primary stimulus for KCl-induced Ca 2ϩ sensitization, and there is strong evidence consistent with the hypothesis that membrane depolarization, rather than increases in [Ca 2ϩ ] i , can cause KCl-induced Ca 2ϩ sensitization (214) . It is also possible that both membrane potential and Ca 2ϩ play roles in Ca 2ϩ sensitivity because in rabbit aorta, the CaMKII inhibitor, KN-93, reduced KCl-but not ionomycin-induced contraction and increase in activated RhoA (167) .
Perhaps the most interesting model was proposed by Morano (124), who speculated, based on smooth muscle myosin II knockout studies, that KCl-induced tonic bladder contraction in neonatal mice is maintained, at least in part, by ROKinduced activation of nonmuscle myosin (see Ref. 123 for review). However, using the same smooth muscle myosin II-deficient neonatal mice, Lohn et al. (115) showed that KCl elevates [Ca 2ϩ ] i but not force, whereas PKC activation using phorbol ester produces sustained cerebral artery contraction without elevating Ca 2ϩ . Thus nonmuscle myosin does not permit force maintenance in cerebral arteries stimulated with KCl. Moreover, because adult arteries do not express significant amounts of nonmuscle myosin (107), a major role for this motor protein in maintenance of strong KCl-induced tonic force in adult arterial muscle seems unlikely.
UNRESOLVED ISSUES
Tissues are heterogeneous mixtures of cell types, and KCl can cause release of neurotransmitters or factors from adjacent cells that activate GPCRs. If appropriate use of selective GPCR antagonists is considered, then the contribution of spurious GPCR activation can usually be eliminated. For example, in rabbit vas deferens, ␣-adrenergic receptor blockade with prazosin abolishes the KCl-induced tonic increase in CPI-17 Thr38 phosphorylation and nearly abolishes tonic force (96) , suggesting that KCl-induced Ca 2ϩ sensitization in this tissue is largely the result of ␣-adrenergic receptor stimulation by norepinephrine released from sympathetic nerves. Although not all studies exploring Ca 2ϩ sensitization induced by KCl included the use of receptor antagonists, studies on the rabbit aorta (167) and femoral artery (150, 202) , pig and cow airway smooth muscle (77) , and rat caudal (121) and mesenteric (9) arteries did apply receptor blockers to eliminate any potential contribution of GPCR activation. The use of ␣-and ␤-adrenergic, H 1 -histaminergic, AT 1 , and thromboxane A 2 receptor blockers by Sakurada et al. (167) provides strong support for the conclusion that KCl acting through smooth muscle membrane depolarization can cause Ca 2ϩ sensitization. The use of primary single cell isolates can also eliminate the potential contribution of paracrine stimuli. However, integrinand elastin-based signaling play important roles in the regulation of cell signaling (Refs. 88, 182, 183, 193 , and reviewed in Ref. 217) , and the loss of, or dramatic alteration in, focal contact tension on disruption of the extracellular matrix permitting isolation of single smooth muscle cells may dramatically alter cell signaling systems leading to contraction. Another complicating factor would arise if increases in [Ca 2ϩ ] i produced on membrane depolarization with KCl caused increased production of autocrine hormones such as sphingosine-1-phosphate and arachidonic acid metabolites (3, 110, 140, 144) . If generated, autocrine agents could activate GPCRs, leading to Ca 2ϩ sensitization, and this contribution to a KClinduced response may not be eliminated even by isolation of single cells. These issues will be resolved only by use of appropriate tissue, cell and molecular models and protocol designs including the use of selective receptor blockers or inhibitors of the production of autocrine and paracrine agents.
Another unresolved issue is the precise identity of the molecular links bridging KCl stimulation with ROK activation. The definitive experiments in smooth muscle have not been done, and whether Ca 2ϩ activates a molecular motor or some other system is not known. The binding partners involved in ROK transport and the signals that initiate and terminate translocation are not known. Also, whether Ca 2ϩ or membrane depolarization plays the principal role in KCl-induced Ca 2ϩ sensitization remains to be determined.
In summary, a general model (Fig. 7) for KCl-induced Ca 2ϩ sensitization must at this time include several possible alternative mechanisms, including Ca 2ϩ -induced colocalization to plasma membrane site(s) such as caveolae or the dystroglycan complex, activation of ROK by RhoA or by arachidonic acid, activation of GPCRs by the generation of paracrine or autocrine agents, and activation of ROK by membrane depolarization independently of changes in [Ca 2ϩ ] i . In addition, the contribution made by other Ca 2ϩ -dependent and -independent enzymes on MLC kinase and phosphatase activities must also Fig. 6 . KCl (110 mM; substituted isosmotically for Na ϩ ) causes an increase in ROK translocation to caveolae at 30 s of stimulation (202) , and this increase was significantly inhibited by 1 M cytochalasin D and 10 M nocodazole, agents that can disrupt, respectively, actin and microtubule cables. Data are means Ϯ SE, n ϭ 3.
be considered in a comprehensive model describing KClinduced Ca 2ϩ sensitization.
SOME FUTURE DIRECTIONS IN KCL-INDUCED CA
2؉
SENSITIVITY RESEARCH
To more fully understand KCl-induced Ca 2ϩ sensitization, some future challenges are to determine the precise mechanism(s) by which Ca 2ϩ or membrane potential causes translocation of ROK to peripheral membrane sites, whether RhoA basally residing at peripheral sites is necessary and sufficient to activate newly translocated ROK, whether additional RhoA becomes activated during stimulation with KCl, and how activated ROK causes sustained activation of MLC phosphorylation to maintain tonic force. This last step presumes that ROK must either directly, through subsequent translocation back to the cytosol, or indirectly, through activation of additional mediators, such as ZIP-like kinase (117) , phosphorylate MYPT1 on more centrally located myofilaments. In the rabbit aorta, KCl increases MYPT1-Thr696 phosphorylation by ϳ50% (167), and our laboratory provides supportive data showing that KCl increases MYPT1-Thr853 phosphorylation in rabbit renal artery (Fig. 8) . Whether KCl-induced tonic contraction is uniquely due to sensitization of nonmuscle myosin (123) must also be resolved. There is a growing list of ]i produced upon membrane depolarization with KCl may cause ROK translocation to caveolin within distinct plasma membrane domains such as caveolae or the dystroglycan complex, where active RhoA (RhoA-GTP) or arachidonic acid activates ROK (ROK*). How ROK is translocated from the cytosol to plasma membrane (PM) sites is not known, but one possible mode of transport is as cargo carried on actin or tubulin cables. Membrane depolarization (⌬EM) rather than increases in [Ca 2ϩ ]i may be responsible for activation of ROK, but the molecular mechanism linking depolarization with ROK activation remains to be determined. Given the documented complexity of KCl-induced regulation of contraction, should K ϩ depolarization still be used as a tool to study smooth muscle physiology? My bias is to answer "yes." There is growing evidence that the mechanisms by which the many GPCR contractile and relaxant stimuli cause smooth muscle contraction differ on a scale ranging from subtle to dramatic. Smooth muscles from different organ systems often display different signaling patterns in response to the same stimulus. There is ample evidence that the type of contraction produced by each stimulus is dependent on stimulus concentration as well as on duration of muscle stimulation. Our laboratory has shown that smooth muscle retains a memory of GPCR activation such that both Ca 2ϩ signaling and Ca 2ϩ sensitization can be altered for minutes to hours after complete cessation of the stimulus (149, 150, 154, 155) . Thus the cell signaling systems regulating smooth muscle contraction also display GPCR activation history dependence. For these reasons, despite its inherent complexity, KCl-induced smooth muscle contraction is still "simpler" than GPCR-induced contraction, and once the cell signaling and contractile protein regulatory systems induced by KCl are completely mapped, responses to KCl can quite accurately be applied for comparison to more fully understand the vastly more complex GPCR-induced regulation of smooth muscle contraction. Perhaps most importantly, just as KCl as a stimulus helped reveal Ca 2ϩ entry signaling defects in hypertension (8, 10, 69, 213) , KCl-induced Ca 2ϩ sensitization is providing insights into signaling dysfunction in certain chronic disease conditions. For example, pig large coronary arteries distal to a chronic occlusion display enhanced KCl-induced, but not enhanced, endothelin-induced Ca 2ϩ sensitivity (62). Y-27632 selectively reduces enhanced KCl-induced contraction in both large and small pulmonary arteries from pulmonary hypertensive rats (129) . In rat mesenteric arteries, KCl produces greater Ca 2ϩ sensitization in spontaneously hypertensive rats than in control normotensive animals (9) . In the rat ileum, inhibition of KCl-induced Ca 2ϩ sensitization by the proinflammatory interleukin-1␤ identifies MYPT1 phosphorylation as a target for dysregulation of smooth muscle in intestinal motility disorders (139) .
In conclusion, KCl remains a valuable tool as a smooth muscle stimulus. Future studies designed to explore KClinduced Ca 2ϩ sensitization will undoubtedly provide new insights and a deeper understanding of spatiotemporal cell signaling paradigms involved in regulation of smooth muscle contraction in health and disease. 
